Comments to OEHHA: Fluroide Hazard Identification Materials Share page: This letter sets forth the scientific and regulatory reasons that fluoride does not meet the Proposition 65 criteria for listing. Download Document Issues: OTC Medicines Fluoride Related Posts Press Releases and Statements CHPA Applauds Bipartisan Bill to Streamline Access to Next-Generation Sunscreens in the U.S. Jun 4, 2025 Comments Comments Regarding Amending OTC Monograph M012: Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Human Use May 7, 2025 Letter Letter Regarding Office of Management & Budget Request for Information: Deregulation May 12, 2025